...
机译:患社区育种治疗对老年基因型2慢性丙型肝炎患者患者的综合治疗
Division of Gastroenterology Department of Internal Medicine Nippon Medical School Chiba Hokusoh;
Core Research Facilities for Basic Science Research Center for Medical Sciences Jikei University;
Division of Gastroenterology Department of Internal Medicine Nippon Medical School Chiba Hokusoh;
Division of Gastroenterology and Hepatology Otakanomori Hospital;
Department of Gastroenterology and Hepatology Shinmatsudo Central General Hospital;
Department of Gastroenterology and Hepatology Shinmatsudo Central General Hospital;
Division of Gastroenterology Department of Internal Medicine Nippon Medical School Chiba Hokusoh;
Division of Gastroenterology Department of Internal Medicine Nippon Medical School Chiba Hokusoh;
Division of Gastroenterology Department of Internal Medicine Nippon Medical School Chiba Hokusoh;
Nagoya City University Graduate School of Medical Sciences;
Nagoya City University Graduate School of Medical Sciences;
Division of Gastroenterology and Hepatology Department of Internal Medicine Nippon Medical School;
Chronic hepatitis; Elderly; Ribavirin; Sofosbuvir;
机译:患社区育种治疗对老年基因型2慢性丙型肝炎患者患者的综合治疗
机译:Leadipasvir和Sofosbuvir的安全性和有效性,有或没有利巴韦林,治疗经验丰富的基因型1丙型肝炎病毒感染和肝硬化
机译:Sofosbuvir,Ribavirin和PEG-IFNα-2a治疗幼稚急性乙型肝炎病毒基因型4的有效性4
机译:HLA-C基因在丙型肝炎病毒中感染埃及患者,估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
机译:利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
机译:韩国基因型2慢性丙型肝炎患者的基于Sofosbuvir的疗法的现实生活效力和安全性重点是利巴韦林剂量
机译:Sofosbuvir Plus利巴韦林治疗幼稚慢性丙基肝炎的疗效和安全性3南旁遮普宫,巴基斯坦